China’s Qiming Venture Partners Leads $37M In AI-Enabled Drug Discovery Start-Up

Sophy Yang
September 10, 2019 — 11:05 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: America Artificial Intelligence Baidu China chinese drug discovery europe Fidelity Google healthcare Hong Kong Insilico Medicine investment Kai-Fu Lee Lilly Asia Ventures medicine North America pharmaceutical Private Equity Qiming Venture Partners search engine singapore Sinovation technology venture capital

Related News:

Chinese Charitable Foundations Expand Into Alternative Investments To Enhance Returns

November 30, 2023 — 23:50

ByteDance’s ChatGPT-Powered AI Chatbot Cici Tops Charts in Emerging Markets

November 29, 2023 — 23:23

ByteDance to Dissolve Gaming Unit After Failing to Find a Buyer

November 28, 2023 — 03:29

Huawei Spins Off Intelligent Automotive Solutions Unit To Secure Fresh Funding

November 27, 2023 — 23:45

ByteDance Establishes New AI Division To Accelerate Consumer Product Deployment

November 27, 2023 — 23:10

Bahrain’s Investcorp Targets RMB2-4 Billion Buyout Fund in China

November 25, 2023 — 00:58

ByteDance to Sell Moonton Gaming Studio in Strategic Retreat From Gaming

November 23, 2023 — 00:00

Tencent-Backed WeBank Saw Rapid Revenue and Profit Expansion

November 20, 2023 — 23:07

Lalamove Drives Global Expansion, Anchoring in Southeast Asia and South America

November 17, 2023 — 23:12